Last update 01 Nov 2024

TgPRP4K x PfCLK3 x VEGFR2 x c-Met x Tie-2

Basic Info

Related Targets
TgPRP4KPfCLK3VEGFR2[+2]

Related

1
Drugs associated with TgPRP4K x PfCLK3 x VEGFR2 x c-Met x Tie-2
Altiratinib
Target
PfCLK3 x TgPRP4K x Tie-2 x VEGFR2 x c-Met
Mechanism
PfCLK3 inhibitors [+4]
Active Org.
University of GrenobleUniversity of Grenoble
Originator Org.
Deciphera Pharmaceuticals, Inc.Deciphera Pharmaceuticals, Inc.
Active Indication
Malaria, Falciparum [+1]
Inactive Indication
Advanced Malignant Solid Neoplasm [+3]
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with TgPRP4K x PfCLK3 x VEGFR2 x c-Met x Tie-2
NCT02228811 / TerminatedPhase 1
A Multicenter Phase 1 Ascending Dose Study of DCC-2701 To Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Advanced Solid Tumors
100 Clinical Results associated with TgPRP4K x PfCLK3 x VEGFR2 x c-Met x Tie-2
Login to view more data
100 Translational Medicine associated with TgPRP4K x PfCLK3 x VEGFR2 x c-Met x Tie-2
Login to view more data
0 Patents (Medical) associated with TgPRP4K x PfCLK3 x VEGFR2 x c-Met x Tie-2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free